Rather, they serve as an adjunctive treatment of a broader OSA management, particularly beneficial for obese patients
Looking at a separate study of people with both obesity and type 2 diabetes, weight loss was understandably slightly lower diabetes medications and metabolic differences often blunt the response but still substantial
GLP-1 receptor agonists like semaglutide and tirzepatide are commercially available in fixed pre-filled pens and certain multidose formats
Tirzepatide was designed to combine two complementary hormonal pathways into a single molecule
Reductions in liver fat are typical, with one study demonstrating an 86% decrease after 48 weeks
In the UK, the storage and handling of licensed medicines is governed primarily by the Medicines and Healthcare products Regulatory Agency (MHRA) , with clinical guidance on specific therapeutic areas provided by the National Institute for Health and Care Excellence (NICE) and the NHS